Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Innate Pharma SA announces today its financial results for the first half of 2010.
August 31, 2010
The key financial elements for the half-year results are as follows :
- Programs on track
- Decrease in operating loss
- Controlled burn rate and strong cash position
| Download Area |
|---|
| CP en français |
| Rapport financier semestriel au 30 juin 2010 |
| PR in English |
| Interim Financial Report June 30, 2010 |